全文获取类型
收费全文 | 831篇 |
免费 | 46篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 69篇 |
妇产科学 | 3篇 |
基础医学 | 80篇 |
口腔科学 | 36篇 |
临床医学 | 107篇 |
内科学 | 178篇 |
皮肤病学 | 23篇 |
神经病学 | 18篇 |
特种医学 | 184篇 |
外科学 | 40篇 |
综合类 | 24篇 |
预防医学 | 43篇 |
眼科学 | 14篇 |
药学 | 50篇 |
中国医学 | 1篇 |
肿瘤学 | 38篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 10篇 |
2020年 | 6篇 |
2019年 | 12篇 |
2018年 | 17篇 |
2017年 | 12篇 |
2016年 | 11篇 |
2015年 | 22篇 |
2014年 | 13篇 |
2013年 | 27篇 |
2012年 | 19篇 |
2011年 | 15篇 |
2010年 | 41篇 |
2009年 | 38篇 |
2008年 | 15篇 |
2007年 | 24篇 |
2006年 | 19篇 |
2005年 | 38篇 |
2004年 | 15篇 |
2003年 | 4篇 |
2002年 | 9篇 |
2001年 | 15篇 |
2000年 | 12篇 |
1999年 | 18篇 |
1998年 | 47篇 |
1997年 | 48篇 |
1996年 | 48篇 |
1995年 | 33篇 |
1994年 | 40篇 |
1993年 | 36篇 |
1992年 | 12篇 |
1991年 | 14篇 |
1990年 | 7篇 |
1989年 | 22篇 |
1988年 | 43篇 |
1987年 | 19篇 |
1986年 | 17篇 |
1985年 | 31篇 |
1984年 | 9篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 12篇 |
1975年 | 4篇 |
1968年 | 2篇 |
排序方式: 共有913条查询结果,搜索用时 15 毫秒
111.
112.
O Godon H Fontaine S Kahi JF Meritet D Scott-Algara S Pol ML Michel M Bourgine ; for the ANRS HB study group 《Molecular therapy》2014,22(3):675-684
A substudy of a phase I/II, prospective, multicenter clinical trial was carried out to investigate the potential benefit of therapeutic vaccination on hepatitis B e antigen-negative patients with chronic hepatitis B (CHB), treated efficiently with analogues. Patients were randomized in 2 arms, one receiving a hepatitis B virus (HBV) envelope DNA vaccine, and one without vaccination. At baseline, HBV-specific interferon (IFN)-γ–producing T cells were detected in both groups after in vitro expansion of peripheral blood mononuclear cells. Vaccine-specific responses remained stable in the vaccine group, whereas in the control group the percentage of patients with HBV-specific IFN-γ–producing T cells decreased over time. The vaccine-specific cytokine-producing T cells were mostly polyfunctional CD4+ T cells, and the proportion of triple cytokine-producer T cells was boosted after DNA injections. However, these T-cell responses did not impact on HBV reactivation after stopping analogue treatment. Importantly, before cessation of treatment serum hepatitis B surface antigen (HBsAg) titers were significantly associated with DNA or HBsAg clearance. Therapeutic vaccination in CHB patients with persistent suppression of HBV replication led to the persistence of T-cell responses, but further improvements should be searched for to control infection after treatment discontinuation. 相似文献
113.
114.
115.
Chemoattractant-induced changes in surface expression and redistribution of a functional ligand for P-selectin on neutrophils 总被引:4,自引:0,他引:4
Adhesion between platelets and neutrophils is mediated through the interaction of P-selectin on activated platelets with a carbohydrate- containing structure on neutrophils, and occurs under both static and shear conditions. Recent studies using flow chambers have shown that neutrophils become activated after binding to surface-adherent platelets expressing P-selectin. The objective of the present study was to investigate the effect of such activation on the interactions of platelet P-selectin with its ligand on neutrophils. Flow cytometric analyses using P-selectin chimeras revealed that activation induced a rapid and marked reduction in chimera binding, with levels of binding decreased by 71% after 15 minutes of stimulation with the chemotactic agent, FMLP. Using a visual assay of platelet-neutrophil rosetting, we showed that the P-selectin ligand was translocated and clustered at the uropod of neutrophils following the shape changes and polarization induced by chemotactic stimulation. Activated neutrophils bound to surface-adherent platelets also displayed the clustering of P-selectin ligand at the uropod, and these neutrophils detached from the platelets when a shear stress (2 dynes/cm2) was applied through the adhesion chamber. These results indicate that chemotactic stimulation of neutrophils induces changes in the surface expression and distribution of a biologically relevant ligand for P-selectin, and that these changes might influence the adhesive interactions occurring between neutrophils and activated platelets. 相似文献
116.
117.
Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission 总被引:2,自引:0,他引:2
Locasciulli A; Gornati G; Tagger A; Ribero ML; Cavalletto D; Cavalletto L; Masera G; Shulman HM; Portmann B; Alberti A 《Blood》1991,78(6):1619-1622
Antibody to the recently identified hepatitis C virus (HCV) was investigated in sera of 50 leukemic children who had chronic liver disease (CLD), observed for 1 to 12.6 years after therapy withdrawal. All patients were tested for anti-HCV at regular intervals: Ortho- enzyme-linked immunosorbent assay (ELISA) test was performed in all cases. Reactive sera were also tested by recombinant immunoblotting assay to define the specificity of the results obtained by ELISA. Twelve cases (24%) were persistently positive (group A), 11 (22%) were transiently anti-HCV+ positive (group B), and 27 (54%) were negative. Mean SGPT peak during follow-up was significantly higher in group A (P = .014, A v B and P less than .00001, A v C). SGPT normalized off- therapy in 1 of 12 cases (group A), 10 of 11 (group B), and 19 of 27 (group C) (P = .0004, A v B and P = .012, A v C). Accordingly, liver histology, available in 37 patients, showed signs of chronic hepatitis in all patients in group A while most patients in group B and C had less severe liver lesions. These results indicate that HCV plays a significant role in the etiology of chronic hepatitis in leukemic patients and that persistent anti-HCV activity correlates with a more severe CLD, which could jeopardize the final prognosis of children cured of leukemia. 相似文献
118.
119.
Annuzzi G Del Prato S Arcari R Bellomo Damato A Benzi L Bruttomesso D Calderini MC Coscelli C Fedele D Galluzzo A Giordano M Giorgino R Lapolla A Orsini P Pagano G Santoro D Riccardi G 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2001,11(3):168-175
BACKGROUND AND AIM: While lispro insulin has been reported to lower postprandial blood glucose concentrations, less consistent effects have been shown for glycosylated hemoglobin (HbA1c) levels. Aim of this study was to determine whether pre-meal association of NPH, an intermediate-acting insulin, with lispro improves overall glycemic control in type 1 diabetic patients. METHODS AND RESULTS: Eighty-five type 1 diabetic patients were studied in a multicenter randomized comparative (human regular vs lispro insulin) crossover (3-month) study in which NPH insulin was given as a dinner or bedtime injection and at breakfast and lunch if necessary. The number of injections was kept constant: 42% and 58% of patients injected insulin 3 and 4 times per day, respectively. Fasting and preprandial blood glucose levels were similar, while postprandial levels improved after lispro compared to human regular insulin (breakfast: 8.28 +/- 2.39 vs 9.28 +/- 2.72 mmol/l; lunch: 8.33 +/- 2.67 vs 9.06 +/- 2.67 mmol/l, dinner: 8.06 +/- 2.72 vs 9.28 +/- 2.44 mmol/l, ANOVA: p = 0.003). HbA1c also improved after lispro: 8.1 +/- 0.9 vs 8.3 +/- 0.8%, p < 0.05. The rate of hypoglycemia was similar. Patients showed better acceptance of lispro treatment (p < 0.001). CONCLUSIONS: Lispro improves overall blood glucose control in type 1 diabetic patients without increasing the incidence of hypoglycemia. This can be achieved by an optimal combination of lispro insulin with NPH whenever the time intervals between meals are too long. 相似文献
120.